Contact Us
  Search
The Business Research Company Logo
Global Next Generation Sequencing (NGS) Sample Preparation Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Next Generation Sequencing (NGS) Sample Preparation Market Report 2026

Global Outlook – By Products And Services (Workstations Or Instruments, Reagents And Consumables, Services), By Workflow (Library Preparation, Target Enrichment, Sample ExtractionOrisolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (Qc), Pooling), By Technology (Nanopore Sequencing, Sequencing By Synthesis (Sbs), Single Molecule Real-time (SMRT) Sequencing, Ion Semiconductor Sequencing), By Application (Diagnostics, Drug Discovery, Biomarker Discovery, Precision Medicine, Agriculture And Animal Research, Other Applications), By End User (Academic Institutes And Research Centers, Hospitals And Clinics, Pharma And Biotech Companies, Other End Users) - Market Size, Trends, And Global Forecast 2026-2035

Next Generation Sequencing (NGS) Sample Preparation Market Overview

• Next Generation Sequencing (NGS) Sample Preparation market size has reached to $3.6 billion in 2025 • Expected to grow to $7.1 billion in 2030 at a compound annual growth rate (CAGR) of 14.5% • Growth Driver: Rising Infectious Disease Cases Fuel Demand For NGS Sample Preparation Market Growth • Market Trend: Digital Microfluidics Platforms Transform NGS Sample Preparation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Next Generation Sequencing (NGS) Sample Preparation Market?

Next-generation sequencing (NGS) sample preparation refers to the process of preparing DNA or RNA samples for sequencing using Next-Generation Sequencing (NGS) technologies. It involves multiple steps such as extraction, quantification, library preparation, and enrichment to ensure the samples are suitable for high-throughput sequencing and accurate genomic analysis. The main types of products and services in a next-generation sequencing (NGS) sample preparation include workstations or instruments, reagents and consumables, and services. Workstations or instruments are specialized devices used for NGS sample preparation and sequencing that automate and streamline the various processes involved in preparing and analyzing genetic material. They are essential for achieving efficient and accurate sequencing results. The workflow types include library preparation, target enrichment, sample extraction or isolation, fragmentation, sample quantification, library quantification, quality control (Qc), and pooling with technology types such as nanopore sequencing, sequencing by synthesis (SBS), single-molecule real-time (SmRT) sequencing, and ion semiconductor sequencing. The applications are categorized into diagnostics, drug discovery, biomarker discovery, precision medicine, agriculture and animal research, others for end users, including academic institutes and research centers, hospitals and clinics, pharmaceutical and biotech companies, and others.
Next Generation Sequencing (NGS) Sample Preparation Market Global Report 2026 Market Report bar graph

What Is The Next Generation Sequencing (NGS) Sample Preparation Market Size and Share 2026?

The next generation sequencing (ngs) sample preparation market size has grown rapidly in recent years. It will grow from $3.6 billion in 2025 to $4.13 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to expansion of genomic research initiatives, rising adoption of ngs in clinical diagnostics, growth in precision medicine programs, increased availability of sequencing instruments, improvements in reagent performance.

What Is The Next Generation Sequencing (NGS) Sample Preparation Market Growth Forecast?

The next generation sequencing (ngs) sample preparation market size is expected to see rapid growth in the next few years. It will grow to $7.1 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing use of ngs in routine diagnostics, rising demand for scalable sample preparation solutions, expansion of oncology and rare disease sequencing, growing investments in automated laboratories, increasing focus on workflow standardization. Major trends in the forecast period include increasing automation of ngs sample preparation workflows, rising demand for high-throughput library preparation kits, growing use of integrated ngs platforms, expansion of target enrichment techniques, enhanced focus on sample quality and reproducibility.

Global Next Generation Sequencing (NGS) Sample Preparation Market Segmentation

1) By Products And Services: Workstations Or Instruments, Reagents And Consumables, Services 2) By Workflow: Library Preparation, Target Enrichment, Sample ExtractionOrisolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (Qc), Pooling 3) By Technology: Nanopore Sequencing, Sequencing By Synthesis (Sbs), Single Molecule Real-time (SMRT) Sequencing, Ion Semiconductor Sequencing 4) By Application: Diagnostics, Drug Discovery, Biomarker Discovery, Precision Medicine, Agriculture And Animal Research, Other Applications 5) By End User: Academic Institutes And Research Centers, Hospitals And Clinics, Pharma And Biotech Companies, Other End Users Subsegments: 1) By Workstations Or Instruments: Automated Sample Preparation Systems, Manual Workstations, Integrated NGS Platforms 2) By Reagents And Consumables: Library Preparation Kits, DNA/RNA Extraction Kits, Amplification Kits, Quality Control Reagents, Consumables 3) By Services: Sample Preparation Services, NGS Workflow Consultation, Training and Support Services, Data Analysis Services

What Is The Driver Of The Next Generation Sequencing (NGS) Sample Preparation Market?

The growing incidence of infectious diseases is expected to propel the growth of the next-generation sequencing (NGS) sample preparation market going forward. Infectious diseases are illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person to another. The growing incidence of infectious diseases is driven by increased global travel, urbanization, climate change, antimicrobial resistance, and emerging new pathogens. Next-generation sequencing sample preparation is crucial in the growing incidence of infectious diseases as it enables rapid and accurate identification of pathogens, helping to monitor outbreaks, track transmission, and guide effective treatment strategies. For instance, in September 2023, according to GOV.UK, a UK-based public sector information site, in the first half of 2023, tuberculosis (TB) cases in England rose by 7% compared to the same period in 2022, with notifications increasing from 2,251 to 2,408. Therefore, the growing incidence of infectious diseases will drive the growth of the next-generation sequencing (NGS) sample preparation market.

Key Players In The Global Next Generation Sequencing (NGS) Sample Preparation Market

Major companies operating in the next generation sequencing (ngs) sample preparation market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company (BD), Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Beckman Coulter, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Novogene Co. Ltd., Tecan Group Ltd, BGI Genomics Co. Ltd., Medgenome Inc., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., Oxford Nanopore Technologies Limited, New England Biolabs Inc., Pacific Biosciences of California Inc., Zymo Research Corporation, Psomagen Inc., Swift Biosciences Inc.

What Are Latest Mergers And Acquisitions In The Next Generation Sequencing (NGS) Sample Preparation Market?

In January 2023, QIAGEN NV, the Netherlands-based biotechnology company, acquired Verogen for $150 million. The acquisition aims to enhance QIAGEN's capabilities in forensic and genetic testing, expanding its product offerings and market reach in the life sciences sector. Verogen is a US-based forensic genomics company that specializes in next-generation sequencing solutions for forensic applications.

Regional Outlook

North America was the largest region in the next generation sequencing (NGS) sample preparation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Next Generation Sequencing (NGS) Sample Preparation Market?

The next generation sequencing (NGS) sample preparation market consists of revenues earned by entities by providing services such as library construction services, PCR amplification services, validation services, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The next generation sequencing (NGS) sample preparation market also includes sales of preparation kits, sample tracking software, automation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Next Generation Sequencing (NGS) Sample Preparation Market Report 2026?

The next generation sequencing (ngs) sample preparation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the next generation sequencing (ngs) sample preparation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Next Generation Sequencing (NGS) Sample Preparation Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$4.13 billion
Revenue Forecast In 2035$7.1 billion
Growth RateCAGR of 14.8% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredProducts And Services, Workflow, Technology, Application, End User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledF. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company (BD), Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Beckman Coulter, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Novogene Co. Ltd., Tecan Group Ltd, BGI Genomics Co. Ltd., Medgenome Inc., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., Oxford Nanopore Technologies Limited, New England Biolabs Inc., Pacific Biosciences of California Inc., Zymo Research Corporation, Psomagen Inc., Swift Biosciences Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us